The estimated Net Worth of Gerald M Lieberman is at least $689 Thousand dollars as of 15 June 2024. Mr. Lieberman owns over 21,108 units of Entera Bio Ltd stock worth over $188,725 and over the last 19 years he sold ENTX stock worth over $0. In addition, he makes $500,117 as Independent Chairman of the Board at Entera Bio Ltd.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Lieberman ENTX stock SEC Form 4 insiders trading
Gerald has made over 12 trades of the Entera Bio Ltd stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 21,108 units of ENTX stock worth $37,572 on 15 June 2024.
The largest trade he's ever made was buying 50,000 units of Entera Bio Ltd stock on 14 November 2022 worth over $28,500. On average, Gerald trades about 7,064 units every 49 days since 2006. As of 15 June 2024 he still owns at least 106,025 units of Entera Bio Ltd stock.
You can see the complete history of Mr. Lieberman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gerald Lieberman biography
Gerald M. Lieberman serves as Independent Chairman of the Board of the Company. Mr. Lieberman is also a member of the board of directors of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in pharmaceuticals and the world’s largest generic drug developer and manufacturer, where he chairs the Audit Committee and serves on both the Human Resources and Compensation Committee and the Finance Committee. He also serves as Chairman of the Board of Directors of DosenRx, Ltd., a Digital health company that has developed a personalized, patient-controlled device for delivering medication. He is also currently a special advisor at Reverence Capital Partners, a private investment firm focused on the middle-market financial services industry. From 2000 to 2009, Mr. Lieberman was an executive at Alliance Bernstein L.P., where he served as President and Chief Operating Officer from 2004 to 2009, as Chief Operating Officer from 2003 to 2004 and as Executive Vice President, Finance and Operations from 2000 to 2003. From 1998 to 2000, he served as Senior Vice President, Finance and Administration at Sanford C. Bernstein & Co., Inc., until it was acquired by Alliance Capital in 2000, forming AllianceBernstein L.P. Prior to that, he served in various executive positions at Fidelity Investments and at Citicorp. Prior to joining Citicorp he was a certified public accountant with Arthur Andersen. He previously served on the board of directors of Forest Laboratories, LLC from 2011 to 2014, Computershare Ltd. from 2010 to 2012 and AllianceBernstein L.P. from 2004 to 2009. Mr. Lieberman received a B.S. Beta Gamma Sigma with honors in business from the University of Connecticut.
What is the salary of Gerald Lieberman?
As the Independent Chairman of the Board of Entera Bio Ltd, the total compensation of Gerald Lieberman at Entera Bio Ltd is $500,117. There are 1 executives at Entera Bio Ltd getting paid more, with Phillip Schwartz having the highest compensation of $722,014.
How old is Gerald Lieberman?
Gerald Lieberman is 73, he's been the Independent Chairman of the Board of Entera Bio Ltd since 2018. There are no older and 18 younger executives at Entera Bio Ltd.
What's Gerald Lieberman's mailing address?
Gerald's mailing address filed with the SEC is KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, L3, 9112002.
Insiders trading at Entera Bio Ltd
Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, and Sean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.
What does Entera Bio Ltd's logo look like?
Complete history of Mr. Lieberman stock trades at AllianceBernstein Lp, Teva- Pharmaceutical Industries, and Entera Bio Ltd
Entera Bio Ltd executives and stock owners
Entera Bio Ltd executives and other stock owners filed with the SEC include:
-
Phillip Schwartz,
President of Research and Development -
Gerald Lieberman,
Independent Chairman of the Board -
Arthur Santora,
Chief Medical Officer -
Dr. Phillip Schwartz Ph.D.,
Exec. VP, Pres of R&D and Director -
Roger Garceau,
Chief Executive Officer, Director -
Hillel Galitzer,
Chief Operating Officer -
Dr. Hillel Galitzer,
Chief Operating Officer -
Dr. Arthur C. Santora II, M.D., Ph.D.,
Chief Medical Officer -
Kiryat Hadassah,
IR Contact Officer -
Miranda Toledano,
Independent Director -
Gerald Ostrov,
Independent Director -
Faith Charles,
Independent Director -
Yonatan Malca,
Director -
Sean Ellis,
Director -
Zeev Bronfeld,
Director -
Jonathan Lieber,
Chief Financial Officer - U.S.-based -
Dana Yaacov-Garbeli,
Chief Financial Officer -
Dr. Roger J. Garceau,
Chief Devel. Advisor & Director -
Ramesh Ratan,
U.S. Chief Financial Officer -
Dana Yaacov-Garbeli CPA,
Chief Financial Officer -
Dr. Spiros Jamas,
CEO & Director -
Haya Taitel,
Director -
Ramesh Ratan,
U.S.based CFO -
Spiros Jamas,
Chief Executive Officer -
Ron Mayron,
Director